Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01623154 · ClinicalTrials.gov registry record · Phase 4
POCone-UBiT-IR300 Pediatric Comparison Study
A Phase 4 study, sponsored by Otsuka America Pharmaceutical.
- Completed
- Registry status
- Phase 4
- Development phase
- 99
- Enrollment target
NCT01623154 is a Phase 4 study that has completed, run by Otsuka America Pharmaceutical. The registered enrollment target is 99 participants.
The verdict
NCT01623154, a Phase 4 study, has completed, sponsored by Otsuka America Pharmaceutical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 99 participants
- Enrollment target
Study Summary
The purpose of this study is to compare between the POCone® to the UBiT®-IR300 in measuring 13CO2/12CO2 ratio in breath samples when used together with the BreathTek® UBT (urea breath test) Kit and the pUHR-CA web-based software program in identifying H. pylori infection in pediatric subjects.
Interventions
- OTHER Pranactin citric solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01623154
The ClinicalTrials.gov registry entry for NCT01623154 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Otsuka America Pharmaceutical, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pranactin citric solution is the first listed.
NCT01623154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01623154 about?
NCT01623154 is a clinical study titled "POCone-UBiT-IR300 Pediatric Comparison Study". The purpose of this study is to compare between the POCone® to the UBiT®-IR300 in measuring 13CO2/12CO2 ratio in breath samples when used together with the BreathTek® UBT (urea breath test) Kit and the pUHR-CA web-based software program in identifying H. pylori infection in pediatric subjects.
What is the current status of trial NCT01623154?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 99 participants. The study started on 2012-07. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01623154?
The interventions under investigation include: Pranactin citric solution (OTHER).
Who is sponsoring clinical trial NCT01623154?
This trial is sponsored by Otsuka America Pharmaceutical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.